These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34265163)

  • 21. Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonists.
    Hansen KB; Mullasseril P; Dawit S; Kurtkaya NL; Yuan H; Vance KM; Orr AG; Kvist T; Ogden KK; Le P; Vellano KM; Lewis I; Kurtkaya S; Du Y; Qui M; Murphy TJ; Snyder JP; Bräuner-Osborne H; Traynelis SF
    J Pharmacol Exp Ther; 2010 Jun; 333(3):650-62. PubMed ID: 20197375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-D-aspartate receptors.
    Hansen KB; Tajima N; Risgaard R; Perszyk RE; Jørgensen L; Vance KM; Ogden KK; Clausen RP; Furukawa H; Traynelis SF
    Mol Pharmacol; 2013 Jul; 84(1):114-27. PubMed ID: 23625947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse.
    Costa BM; Feng B; Tsintsadze TS; Morley RM; Irvine MW; Tsintsadze V; Lozovaya NA; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2009 Nov; 331(2):618-26. PubMed ID: 19684252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local constraints in either the GluN1 or GluN2 subunit equally impair NMDA receptor pore opening.
    Talukder I; Wollmuth LP
    J Gen Physiol; 2011 Aug; 138(2):179-94. PubMed ID: 21746848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The human NMDA receptor GluN2A
    Marwick KFM; Skehel PA; Hardingham GE; Wyllie DJA
    Pharmacol Res Perspect; 2019 Aug; 7(4):e00495. PubMed ID: 31249692
    [No Abstract]   [Full Text] [Related]  

  • 26. Intersubunit interactions at putative sites of ethanol action in the M3 and M4 domains of the NMDA receptor GluN1 and GluN2B subunits.
    Zhao Y; Ren H; Peoples RW
    Br J Pharmacol; 2016 Jun; 173(12):1950-65. PubMed ID: 27010645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-dependent effects on social interaction of NMDA GluN2A receptor subtype-selective antagonism.
    Green TL; Burket JA; Deutsch SI
    Brain Res Bull; 2016 Jul; 125():159-67. PubMed ID: 27378651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Properties of Triheteromeric
    Yi F; Zachariassen LG; Dorsett KN; Hansen KB
    Mol Pharmacol; 2018 May; 93(5):453-467. PubMed ID: 29483146
    [No Abstract]   [Full Text] [Related]  

  • 29. Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.
    Yi F; Mou TC; Dorsett KN; Volkmann RA; Menniti FS; Sprang SR; Hansen KB
    Neuron; 2016 Sep; 91(6):1316-1329. PubMed ID: 27618671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional assessment of triheteromeric NMDA receptors containing a human variant associated with epilepsy.
    Marwick KFM; Hansen KB; Skehel PA; Hardingham GE; Wyllie DJA
    J Physiol; 2019 Mar; 597(6):1691-1704. PubMed ID: 30604514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative allosteric modulation of GluN1/GluN3 NMDA receptors.
    Zhu Z; Yi F; Epplin MP; Liu D; Summer SL; Mizu R; Shaulsky G; XiangWei W; Tang W; Burger PB; Menaldino DS; Myers SJ; Liotta DC; Hansen KB; Yuan H; Traynelis SF
    Neuropharmacology; 2020 Oct; 176():108117. PubMed ID: 32389749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inhibitory potency of local anesthetics on NMDA receptor signalling depends on their structural features.
    Gronwald C; Vegh V; Hollmann MW; Hahnenkamp A; Garaj V; Hahnenkamp K
    Eur J Pharmacol; 2012 Jan; 674(1):13-9. PubMed ID: 22079424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity of N-methyl-D-aspartate receptor-mediated excitatory postsynaptic potentials and synaptic plasticity to TCN 201 and TCN 213 in rat hippocampal slices.
    Izumi Y; Zorumski CF
    J Pharmacol Exp Ther; 2015 Feb; 352(2):267-73. PubMed ID: 25413830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of the Mg2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1/GluN2A NMDARs.
    Otton HJ; Lawson McLean A; Pannozzo MA; Davies CH; Wyllie DJ
    Neuropharmacology; 2011; 60(2-3):388-96. PubMed ID: 20955720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
    Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
    Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An alternating GluN1-2-1-2 subunit arrangement in mature NMDA receptors.
    Riou M; Stroebel D; Edwardson JM; Paoletti P
    PLoS One; 2012; 7(4):e35134. PubMed ID: 22493736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
    Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
    PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators.
    Zimmerman SS; Khatri A; Garnier-Amblard EC; Mullasseril P; Kurtkaya NL; Gyoneva S; Hansen KB; Traynelis SF; Liotta DC
    J Med Chem; 2014 Mar; 57(6):2334-56. PubMed ID: 24512267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of triheteromeric N-Methyl-D-Aspartate Receptors.
    Cheriyan J; Balsara RD; Hansen KB; Castellino FJ
    Neurosci Lett; 2016 Mar; 617():240-6. PubMed ID: 26917100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptors.
    Santangelo Freel RM; Ogden KK; Strong KL; Khatri A; Chepiga KM; Jensen HS; Traynelis SF; Liotta DC
    J Med Chem; 2013 Jul; 56(13):5351-81. PubMed ID: 23627311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.